作者回应：脓毒症免疫调节治疗的见解
Author Response: Insights into Immunomodulatory Therapy for Sepsis.
作者信息
Ghosh Indranil, Sangha Sukhwinder S, Pandey Gaurav, Srivastava Atul
机构信息
Department of Medicine and Nephrology, Army Hospital (R & R), New Delhi, India.
Department of Medicine and Nephrology, Command Hospital, Chandimandir, Panchkula, Haryana, India.
出版信息
Indian J Crit Care Med. 2025 Jan;29(1):91. doi: 10.5005/jp-journals-10071-24874. Epub 2024 Dec 30.
Abstract
Ghosh I, Sangha SS, Pandey G, Srivastava A. Author Response: Insights into Immunomodulatory Therapy for Sepsis. Indian J Crit Care Med 2025;29(1):91.
摘要
戈什I、桑加SS、潘迪G、斯里瓦斯塔瓦A。作者回复：脓毒症免疫调节治疗的见解。《印度重症监护医学杂志》2025年；29(1)：91。
相似文献
1
Author Response: Insights into Immunomodulatory Therapy for Sepsis.
Indian J Crit Care Med. 2025 Jan;29(1):91. doi: 10.5005/jp-journals-10071-24874. Epub 2024 Dec 30.
2
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.
Indian J Crit Care Med. 2024 Oct;28(10):930-934. doi: 10.5005/jp-journals-10071-24805. Epub 2024 Sep 30.
3
Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations.
Indian J Crit Care Med. 2025 Jan;29(1):90. doi: 10.5005/jp-journals-10071-24847. Epub 2024 Dec 30.
4
Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?
Indian J Crit Care Med. 2024 Oct;28(10):903-905. doi: 10.5005/jp-journals-10071-24816. Epub 2024 Sep 30.
5
The Sepsis Score Dilemma: Balancing Precision and Utility.
Indian J Crit Care Med. 2024 Oct;28(10):906-907. doi: 10.5005/jp-journals-10071-24814. Epub 2024 Sep 30.
6
To C or not to C? Designing a Pragmatic Trial to Deploy a Novel Immunomodulatory Therapy to Fight Organ Dysfunction in Sepsis.
Indian J Crit Care Med. 2024 Mar;28(3):311. doi: 10.5005/jp-journals-10071-24636.
7
Author Response.
Indian J Crit Care Med. 2024 Apr;28(4):408-409. doi: 10.5005/jp-journals-10071-24685.
8
Author Reply: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study.
Indian J Crit Care Med. 2023 Aug;27(8):603-604. doi: 10.5005/jp-journals-10071-24514.
9
Extracorporeal Therapy in Sepsis.
Indian J Crit Care Med. 2020 Apr;24(Suppl 3):S117-S121. doi: 10.5005/jp-journals-10071-23382.
10
Author Response: Appropriately Designed Studies are Needed before Thiamine and Vitamin C Plus Hydrocortisone are Judged Nonbeneficial in Septic Shock.
Indian J Crit Care Med. 2025 Feb;29(2):193-194. doi: 10.5005/jp-journals-10071-24902. Epub 2024 Dec 30.
本文引用的文献
1
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.
Indian J Crit Care Med. 2024 Oct;28(10):930-934. doi: 10.5005/jp-journals-10071-24805. Epub 2024 Sep 30.
2
Approach to Intensive Care Costing and Provision of Cost-effective Care.
Indian J Crit Care Med. 2023 Dec;27(12):876-887. doi: 10.5005/jp-journals-10071-24576.
3
COST OF INTENSIVE CARE IN INDIA.
Int J Technol Assess Health Care. 2016 Jan;32(4):241-245. doi: 10.1017/S0266462316000398. Epub 2016 Sep 9.
4
Daily cost of an intensive care unit day: the contribution of mechanical ventilation.
Crit Care Med. 2005 Jun;33(6):1266-71. doi: 10.1097/01.ccm.0000164543.14619.00.
Zotero 插件